Bank of New York Mellon
IBIO icon

Bank of New York Mellon’s iBio IBIO Stock Holding History

Bank of New York Mellon’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.6K Buy
+10,637
New +$19K ﹤0.01% 4267
2023
Q3 		– Sell
-4,374
Closed -$53.4K – 4375
2023
Q2 		$53.4K Sell
4,374
-29
-0.7% -$547 ﹤0.01% 4170
2023
Q1 		$183K Buy
+4,403
New +$113K ﹤0.01% 3943
2022
Q4 		– Sell
-259
Closed -$22K – 4506
2022
Q3 		$22K Hold
259
– – ﹤0.01% 4442
2022
Q2 		$34K Sell
259
-1,183
-82% -$178K ﹤0.01% 4427
2022
Q1 		$309K Sell
1,442
-37
-3% -$7.74K ﹤0.01% 3999
2021
Q4 		$406K Buy
1,479
+24
+2% +$9.15K ﹤0.01% 3923
2021
Q3 		$771K Buy
1,455
+233
+19% +$145K ﹤0.01% 3555
2021
Q2 		$922K Buy
1,222
+200
+20% +$146K ﹤0.01% 3475
2021
Q1 		$787K Buy
1,022
+167
+20% +$145K ﹤0.01% 3471
2020
Q4 		$449K Buy
855
+469
+122% +$382K ﹤0.01% 3670
2020
Q3 		$391K Buy
386
+70
+22% +$101K ﹤0.01% 3603
2020
Q2 		$351K Buy
316
+223
+240% +$146K ﹤0.01% 3639
2020
Q1 		$49K Buy
+93
New +$35.8K ﹤0.01% 3973
2018
Q2 		– Sell
-18
Closed -$20K – 4253
2018
Q1 		$20K Buy
18
+3
+20% +$3.15K ﹤0.01% 4269
2017
Q4 		$13K Buy
15
+1
+7% +$1.28K ﹤0.01% 4320
2017
Q3 		$22K Hold
14
– – ﹤0.01% 4207
2017
Q2 		$27K Sell
14
-3
-18% -$5.88K ﹤0.01% 4202
2017
Q1 		$37K Buy
17
+3
+21% +$6.24K ﹤0.01% 4172
2016
Q4 		$27K Sell
14
-1
-7% -$2.33K ﹤0.01% 4193
2016
Q3 		$40K Sell
15
-2
-12% -$6.27K ﹤0.01% 4167
2016
Q2 		$62K Hold
17
– – ﹤0.01% 4139
2016
Q1 		$48K Hold
17
– – ﹤0.01% 4091
2015
Q4 		$48K Hold
17
– – ﹤0.01% 4192
2015
Q3 		$58K Hold
17
– – ﹤0.01% 4225
2015
Q2 		$81K Buy
17
+3
+21% +$13.9K ﹤0.01% 4082
2015
Q1 		$56K Hold
14
– – ﹤0.01% 4132
2014
Q4 		$50K Buy
+14
New +$74.7K ﹤0.01% 4144

Other funds holding IBIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
NCM
Noesis Capital Mangement Boca Raton, Florida $832M AUM 49.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAAG
Innovative Asset Advisors Group Shelton, Connecticut $229M AUM
SIM
Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.45B AUM

Bank of New York Mellon's IBIO Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in iBio (IBIO) in Q2 2026: 10,637 shares worth $18.6K. The stake represents ﹤0.01% of the portfolio and ranks #4267 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in IBIO as recently as Q2 2023.

Bank of New York Mellon first reported a position in IBIO in Q4 2014 and has held it in 28 quarters since. The position peaked at $922K in Q2 2021. 17 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • Bank of New York Mellon held 10,637 shares of iBio worth $18.6K as of Q2 2026.
  • iBio was a new Bank of New York Mellon position in Q2 2026.
  • iBio made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #4267 holding.
  • Bank of New York Mellon first reported a position in iBio in Q4 2014 and has held it in 28 quarters since.
  • Bank of New York Mellon's iBio position peaked at $922K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.